OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Oncolytic and local immunotherapy

Original research

OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study

Online download statistics by month:

Online download statistics by month: April 2022 to August 2024

	Abstract	Full	Pdf
Apr 2022	504	530	218
May 2022	221	234	83
Jun 2022	165	169	48
Jul 2022	125	128	49
Aug 2022	137	139	33
Sep 2022	161	165	52
Oct 2022	130	135	46
Nov 2022	100	100	38
Dec 2022	95	95	25
Jan 2023	87	89	42
Feb 2023	110	110	44
Mar 2023	64	64	34
Apr 2023	59	59	29
May 2023	44	44	15
Jun 2023	53	53	23
Jul 2023	44	44	23
Aug 2023	62	62	24
Sep 2023	46	47	27
Oct 2023	32	32	22
Nov 2023	45	45	23
Dec 2023	44	44	39
Jan 2024	30	31	22
Feb 2024	43	43	19
Mar 2024	51	53	25
Apr 2024	50	50	33
May 2024	58	70	31
Jun 2024	36	37	22
Jul 2024	61	65	26
Aug 2024	48	58	31
Total	2705	2795	1146